Author:
Roy C.,Foz A.,Segura C.,Tirado M.,Teixell M.,Teruel D.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference10 articles.
1. Gadebusch, H. H., Shungu, D. L., Weinberg, E., Chung, S. K. Comparison of the antibacterial activity of norfloxacin (MKO366, AM715), a new organic acid, with that of other orally absorbed chemotherapeutic agents. Infection 10 (1982) 41–44.
2. Matsumoto, J. I., Miyamoto, T., Minamida, A., Nishimura, Y., Egawa, H., Nishimura, H. Structure-activity relationships of 4-oxo-1,8-naphthyridine-3-carboxylic acids including AT-2266, a new oral antipseudomonal agent. In:Nelson, J. D., Grassi, C. (eds.): Current chemotherapy and infectious disease. American Society for Microbiology, Washington, D.C. 1980, p. 454.
3. Sato, K., Matsuura, Y., Inoue, M., Une, T., Osada, Y., Ogawa, H., Mitsuhashi, S. In vitro andin vivo activity of DL-8280, a new oxazine derivative. Antimicrob. Agents. Chemother. 22 (1982) 548–553.
4. Bauernfeind, A., Petermüller, C. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur. J. Clin. Microbiol. 2 (1983) 111–115.
5. Wise, R., Andrews, J. M., Edwards, L. J. In vitro activity of BAYo 9867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23 (1983) 559–564.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献